147 related articles for article (PubMed ID: 28116886)
1. Normalization of cardiovascular risk factors in peri-menopausal women with Pycnogenol®.
Luzzi R; Belcaro G; Hosoi M; Feragalli B; Cornelli U; Dugall M; Ledda A
Minerva Ginecol; 2017 Feb; 69(1):29-34. PubMed ID: 28116886
[TBL] [Abstract][Full Text] [Related]
2. Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition.
Errichi S; Bottari A; Belcaro G; Cesarone MR; Hosoi M; Cornelli U; Dugall M; Ledda A; Feragalli B
Panminerva Med; 2011 Sep; 53(3 Suppl 1):65-70. PubMed ID: 22108479
[TBL] [Abstract][Full Text] [Related]
3. Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study.
Hu S; Belcaro G; Cornelli U; Luzzi R; Cesarone M; Dugall M; Feragalli B; Errichi B; Ippolito E; Grossi M; Hosoi M; Gizzi G; Trignani M
Int Angiol; 2015 Feb; 34(1):43-52. PubMed ID: 25391252
[TBL] [Abstract][Full Text] [Related]
4. The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress.
Belcaro G; Dugall M; Ippolito E; Hu S; Saggino A; Feragalli B
J Neurosurg Sci; 2015 Dec; 59(4):437-46. PubMed ID: 26635191
[TBL] [Abstract][Full Text] [Related]
5. Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55.
Belcaro G; Luzzi R; Dugall M; Ippolito E; Saggino A
J Neurosurg Sci; 2014 Dec; 58(4):239-48. PubMed ID: 24675223
[TBL] [Abstract][Full Text] [Related]
6. Pycnogenol® supplementation improves health risk factors in subjects with metabolic syndrome.
Belcaro G; Cornelli U; Luzzi R; Cesarone MR; Dugall M; Feragalli B; Errichi S; Ippolito E; Grossi MG; Hosoi M; Cornelli M; Gizzi G
Phytother Res; 2013 Oct; 27(10):1572-8. PubMed ID: 23359520
[TBL] [Abstract][Full Text] [Related]
7. Lady Prelox® improves sexual function in generally healthy women of reproductive age.
Bottari A; Belcaro G; Ledda A; Luzzi R; Cesarone MR; Dugall M
Minerva Ginecol; 2013 Aug; 65(4):435-44. PubMed ID: 24051943
[TBL] [Abstract][Full Text] [Related]
8. Prevention of vaginal dryness in perimenopausal women. Supplementation with Lady Prelox®.
Cesarone MR; Belcaro G; Scipione C; Scipione V; Dugall M; Hu S; Cotellese R; Feragalli B; Ledda A
Minerva Ginecol; 2019 Dec; 71(6):434-441. PubMed ID: 32064827
[TBL] [Abstract][Full Text] [Related]
9. Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression.
Belcaro G; Ippolito E; Dugall M; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Steigerwalt RD; Cesarone MR; Pellegrini L; Luzzi R; Corsi M
Int Angiol; 2015 Apr; 34(2):150-7. PubMed ID: 25519846
[TBL] [Abstract][Full Text] [Related]
10. Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation.
Belcaro G; Luzzi R; Hu S; Cesarone MR; Dugall M; Ippolito E; Corsi M; Caporale S
Panminerva Med; 2014 Mar; 56(1):41-8. PubMed ID: 24637472
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic myalgic pain (fibromyalgia): supportive management and prevention with Pycnogenol®.
Belcaro G; Hu S; Cesarone MR; Dugall M; Scipione C; Scipione V; Hosoi M; Ledda A; Cornelli U; Feragalli B; Cotellese R
Panminerva Med; 2021 Mar; 63(1):46-50. PubMed ID: 33541059
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19).
Belcaro G; Cornelli U; Cesarone MR; Scipione C; Scipione V; Hu S; Feragalli B; Corsi M; Cox D; Cotellese R; Hosoi M; Burki C
Minerva Med; 2022 Apr; 113(2):300-308. PubMed ID: 34060731
[TBL] [Abstract][Full Text] [Related]
13. Central cardiovascular calcifications: supplementation with Pycnogenol® and Centellicum®: variations over 12 months.
Hu S; Belcaro G; Cesarone MR; Feragalli B; Cotellese R; Dugall M; Scipione C; Scipione V; Maione C
Minerva Cardioangiol; 2020 Feb; 68(1):22-26. PubMed ID: 31633315
[TBL] [Abstract][Full Text] [Related]
14. Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol.
Belcaro G; Cesarone MR; Errichi S; Zulli C; Errichi BM; Vinciguerra G; Ledda A; Di Renzo A; Stuard S; Dugall M; Pellegrini L; Gizzi G; Ippolito E; Ricci A; Cacchio M; Cipollone G; Ruffini I; Fano F; Hosoi M; Rohdewald P
Redox Rep; 2008; 13(6):271-6. PubMed ID: 19017467
[TBL] [Abstract][Full Text] [Related]
15. Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women?
Cagnacci A; Palma F; Romani C; Xholli A; Bellafronte M; Di Carlo C
Gynecol Endocrinol; 2015 May; 31(5):359-62. PubMed ID: 25585548
[TBL] [Abstract][Full Text] [Related]
16. Pycnogenol® and Centella asiatica to prevent asymptomatic atherosclerosis progression in clinical events.
Belcaro G; Dugall M; Ippolito E; Hosoi M; Cornelli U; Ledda A; Scoccianti M; Cesarone MR; Pellegrini L; Luzzi R; Corsi M; Feragalli B
Minerva Cardioangiol; 2017 Feb; 65(1):24-31. PubMed ID: 26505327
[TBL] [Abstract][Full Text] [Related]
17. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
18. Carotid plaque stabilization induced by the supplement association Pycnogenol® and centella asiatica (Centellicum®).
Luzzi R; Belcaro G; Ippolito E
Minerva Cardioangiol; 2016 Dec; 64(6):603-9. PubMed ID: 26496510
[TBL] [Abstract][Full Text] [Related]
19. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women.
Matthews KA; Wing RR; Kuller LH; Meilahn EN; Plantinga P
Arch Intern Med; 1994 Oct; 154(20):2349-55. PubMed ID: 7944857
[TBL] [Abstract][Full Text] [Related]
20. Delayed progression of atherosclerosis and cardiovascular events in asymptomatic patients with atherosclerotic plaques: 3-year prevention with the supplementation with Pycnogenol®+Centellicum®.
Belcaro G; Cesarone MR; Scipione C; Scipione V; Dugall M; Shu H; Peterzan P; Corsi M; Luzzi R; Hosoi M; Feragalli B; Cotellese R
Minerva Cardioangiol; 2020 Feb; 68(1):15-21. PubMed ID: 31625707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
